| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.50e-04 | 188 | 29 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 4.62e-04 | 22 | 29 | 2 | GO:0016500 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 2.74e-05 | 130 | 28 | 4 | GO:1901655 | |
| GeneOntologyBiologicalProcess | odontogenesis | 4.93e-05 | 151 | 28 | 4 | GO:0042476 | |
| GeneOntologyBiologicalProcess | exocrine system development | 6.24e-05 | 57 | 28 | 3 | GO:0035272 | |
| GeneOntologyBiologicalProcess | cellular response to aldosterone | 6.36e-05 | 9 | 28 | 2 | GO:1904045 | |
| GeneOntologyBiologicalProcess | cellular response to mineralocorticoid stimulus | 1.60e-04 | 14 | 28 | 2 | GO:0071389 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 1.78e-04 | 81 | 28 | 3 | GO:0071384 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.89e-04 | 239 | 28 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | response to aldosterone | 3.33e-04 | 20 | 28 | 2 | GO:1904044 | |
| GeneOntologyBiologicalProcess | cellular response to aldehyde | 3.33e-04 | 20 | 28 | 2 | GO:0110096 | |
| GeneOntologyBiologicalProcess | response to ketone | 3.64e-04 | 254 | 28 | 4 | GO:1901654 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.16e-06 | 656 | 29 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.21e-06 | 658 | 29 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.46e-05 | 530 | 29 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | basement membrane | 6.34e-04 | 122 | 29 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | synaptic cleft | 9.55e-04 | 33 | 29 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | sperm flagellum | 3.18e-03 | 214 | 29 | 3 | GO:0036126 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 4.28e-03 | 238 | 29 | 3 | GO:0097729 | |
| MousePheno | abnormal conjunctival epithelium morphology | 5.90e-05 | 7 | 24 | 2 | MP:0004481 | |
| MousePheno | decreased dentate gyrus size | 7.86e-05 | 8 | 24 | 2 | MP:0012460 | |
| Domain | VWC_out | 1.79e-08 | 19 | 29 | 4 | SM00215 | |
| Domain | VWC | 3.34e-07 | 38 | 29 | 4 | SM00214 | |
| Domain | VWFC_2 | 3.34e-07 | 38 | 29 | 4 | PS50184 | |
| Domain | VWF_dom | 5.04e-07 | 42 | 29 | 4 | IPR001007 | |
| Domain | TIL | 7.34e-07 | 12 | 29 | 3 | PF01826 | |
| Domain | C8 | 7.34e-07 | 12 | 29 | 3 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 9.53e-07 | 13 | 29 | 3 | IPR014853 | |
| Domain | C8 | 9.53e-07 | 13 | 29 | 3 | SM00832 | |
| Domain | TIL_dom | 1.21e-06 | 14 | 29 | 3 | IPR002919 | |
| Domain | VWFD | 1.86e-06 | 16 | 29 | 3 | PS51233 | |
| Domain | VWD | 1.86e-06 | 16 | 29 | 3 | SM00216 | |
| Domain | VWF_type-D | 1.86e-06 | 16 | 29 | 3 | IPR001846 | |
| Domain | VWD | 1.86e-06 | 16 | 29 | 3 | PF00094 | |
| Domain | EGF_1 | 2.23e-06 | 255 | 29 | 6 | PS00022 | |
| Domain | CTCK_1 | 2.70e-06 | 18 | 29 | 3 | PS01185 | |
| Domain | Cys_knot_C | 7.57e-06 | 25 | 29 | 3 | IPR006207 | |
| Domain | CTCK_2 | 7.57e-06 | 25 | 29 | 3 | PS01225 | |
| Domain | Laminin_aI | 2.32e-05 | 5 | 29 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.32e-05 | 5 | 29 | 2 | PF06008 | |
| Domain | Laminin_II | 2.32e-05 | 5 | 29 | 2 | PF06009 | |
| Domain | Laminin_domII | 2.32e-05 | 5 | 29 | 2 | IPR010307 | |
| Domain | VWFC_1 | 2.32e-05 | 36 | 29 | 3 | PS01208 | |
| Domain | EGF | 2.80e-05 | 235 | 29 | 5 | SM00181 | |
| Domain | EGF-like_dom | 3.70e-05 | 249 | 29 | 5 | IPR000742 | |
| Domain | EGF-like_CS | 4.63e-05 | 261 | 29 | 5 | IPR013032 | |
| Domain | EGF_2 | 4.98e-05 | 265 | 29 | 5 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 9.45e-05 | 156 | 29 | 4 | IPR009030 | |
| Domain | EGF_3 | 4.53e-04 | 235 | 29 | 4 | PS50026 | |
| Domain | CT | 5.27e-04 | 22 | 29 | 2 | SM00041 | |
| Domain | EGF | 9.64e-04 | 126 | 29 | 3 | PF00008 | |
| Domain | EGF_LAM_2 | 9.86e-04 | 30 | 29 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 9.86e-04 | 30 | 29 | 2 | PS01248 | |
| Domain | Laminin_EGF | 1.34e-03 | 35 | 29 | 2 | PF00053 | |
| Domain | EGF_Lam | 1.34e-03 | 35 | 29 | 2 | SM00180 | |
| Domain | LAM_G_DOMAIN | 1.58e-03 | 38 | 29 | 2 | PS50025 | |
| Domain | Laminin_EGF | 1.58e-03 | 38 | 29 | 2 | IPR002049 | |
| Domain | Laminin_G_2 | 1.75e-03 | 40 | 29 | 2 | PF02210 | |
| Domain | LDLR_class-A_CS | 1.75e-03 | 40 | 29 | 2 | IPR023415 | |
| Domain | LamG | 2.11e-03 | 44 | 29 | 2 | SM00282 | |
| Domain | Ldl_recept_a | 2.21e-03 | 45 | 29 | 2 | PF00057 | |
| Domain | - | 2.31e-03 | 46 | 29 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.51e-03 | 48 | 29 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.62e-03 | 49 | 29 | 2 | IPR002172 | |
| Domain | LDLa | 2.62e-03 | 49 | 29 | 2 | SM00192 | |
| Domain | LDLRA_2 | 2.62e-03 | 49 | 29 | 2 | PS50068 | |
| Domain | Laminin_G | 3.65e-03 | 58 | 29 | 2 | IPR001791 | |
| Domain | EGF_extracell | 3.90e-03 | 60 | 29 | 2 | IPR013111 | |
| Domain | EGF_2 | 3.90e-03 | 60 | 29 | 2 | PF07974 | |
| Domain | EGF_CA | 7.85e-03 | 86 | 29 | 2 | PF07645 | |
| Pathway | WP_CANCER_PATHWAYS | 9.59e-05 | 507 | 22 | 6 | M48302 | |
| Pubmed | 3.28e-07 | 175 | 29 | 5 | 28071719 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 24691446 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 18523231 | ||
| Pubmed | Screening of integrin-binding peptides from the laminin α4 and α5 chain G domain peptide library. | 6.71e-07 | 2 | 29 | 2 | 22391228 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 18496706 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 19396173 | ||
| Pubmed | Peptides derived from the human laminin alpha4 and alpha5 chains exhibit antimicrobial activity. | 6.71e-07 | 2 | 29 | 2 | 20433883 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 31343575 | ||
| Pubmed | 7.94e-07 | 22 | 29 | 3 | 28334989 | ||
| Pubmed | 9.13e-07 | 23 | 29 | 3 | 29981310 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 1.88e-06 | 29 | 29 | 3 | 21402740 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 31882770 | ||
| Pubmed | Endothelial basement membrane laminin 511 is essential for shear stress response. | 2.01e-06 | 3 | 29 | 2 | 27940654 | |
| Pubmed | Lgr6 marks nail stem cells and is required for digit tip regeneration. | 2.01e-06 | 3 | 29 | 2 | 26460010 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 28147279 | ||
| Pubmed | Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. | 2.01e-06 | 3 | 29 | 2 | 12393739 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 10364433 | ||
| Pubmed | The role of laminins in the organization and function of neuromuscular junctions. | 2.01e-06 | 3 | 29 | 2 | 27614294 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 33972551 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 22691042 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 34128985 | ||
| Pubmed | Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. | 6.70e-06 | 5 | 29 | 2 | 18794334 | |
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 6.70e-06 | 5 | 29 | 2 | 9415429 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 9271224 | ||
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 6.70e-06 | 5 | 29 | 2 | 9389447 | |
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 9.95e-06 | 50 | 29 | 3 | 24191021 | |
| Pubmed | A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. | 1.00e-05 | 6 | 29 | 2 | 18817539 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 19110483 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 9597096 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 14557481 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 33480845 | ||
| Pubmed | 1.48e-05 | 57 | 29 | 3 | 19263529 | ||
| Pubmed | 1.48e-05 | 57 | 29 | 3 | 19479237 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 24139799 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 9438420 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 36641754 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 9852162 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 38820498 | ||
| Pubmed | 2.10e-05 | 64 | 29 | 3 | 19131662 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.12e-05 | 1489 | 29 | 8 | 28611215 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 9882526 | ||
| Pubmed | 2.87e-05 | 71 | 29 | 3 | 33541421 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 9034910 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 3.01e-05 | 10 | 29 | 2 | 18590826 | |
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 11784026 | ||
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 3.01e-05 | 10 | 29 | 2 | 20976766 | |
| Pubmed | Respiratory distress and perinatal lethality in Nedd4-2-deficient mice. | 3.68e-05 | 11 | 29 | 2 | 21505443 | |
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 12051813 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 3.68e-05 | 11 | 29 | 2 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 3.68e-05 | 11 | 29 | 2 | 23472759 | |
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 11381080 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 16750824 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 9396756 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.61e-05 | 1201 | 29 | 7 | 35696571 | |
| Pubmed | 5.21e-05 | 13 | 29 | 2 | 36350252 | ||
| Pubmed | Regional regulation of Filiform tongue papillae development by Ikkα/Irf6. | 5.21e-05 | 13 | 29 | 2 | 27302476 | |
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 5.21e-05 | 13 | 29 | 2 | 21900571 | |
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 9151674 | ||
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 36347239 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 7.00e-05 | 15 | 29 | 2 | 15895400 | |
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 10625553 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 7.00e-05 | 15 | 29 | 2 | 12921739 | |
| Pubmed | Cell-matrix signals specify bone endothelial cells during developmental osteogenesis. | 8.00e-05 | 16 | 29 | 2 | 28218908 | |
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 17601529 | ||
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 29859889 | ||
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 8.00e-05 | 16 | 29 | 2 | 21067603 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 8.22e-05 | 101 | 29 | 3 | 23382219 | |
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 21983115 | ||
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 27559308 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 9.06e-05 | 17 | 29 | 2 | 15056720 | |
| Pubmed | Marker genes identify three somatic cell types in the fetal mouse ovary. | 9.06e-05 | 17 | 29 | 2 | 25158167 | |
| Pubmed | 9.23e-05 | 105 | 29 | 3 | 9628581 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.02e-04 | 18 | 29 | 2 | 18834073 | |
| Pubmed | 1.02e-04 | 18 | 29 | 2 | 19584075 | ||
| Pubmed | 1.02e-04 | 18 | 29 | 2 | 11311202 | ||
| Pubmed | Primary cilia maintain corneal epithelial homeostasis by regulation of the Notch signaling pathway. | 1.14e-04 | 19 | 29 | 2 | 27122169 | |
| Pubmed | 1.14e-04 | 19 | 29 | 2 | 25043473 | ||
| Pubmed | Independent functions and mechanisms for homeobox gene Barx1 in patterning mouse stomach and spleen. | 1.14e-04 | 19 | 29 | 2 | 17855428 | |
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 22911573 | ||
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 1.40e-04 | 21 | 29 | 2 | 22767514 | |
| Pubmed | 1.50e-04 | 326 | 29 | 4 | 17015433 | ||
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 35902588 | ||
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 28963472 | ||
| Pubmed | WNT4 and RSPO1 together are required for cell proliferation in the early mouse gonad. | 1.53e-04 | 22 | 29 | 2 | 23095882 | |
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 22366192 | ||
| Pubmed | Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. | 1.68e-04 | 23 | 29 | 2 | 24680895 | |
| Pubmed | Neonatal Wnt-dependent Lgr5 positive stem cells are essential for uterine gland development. | 1.83e-04 | 24 | 29 | 2 | 31772170 | |
| Pubmed | Fgfr2 is required for the expansion of the early adrenocortical primordium. | 1.83e-04 | 24 | 29 | 2 | 26141512 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 1.99e-04 | 25 | 29 | 2 | 19373938 | |
| Pubmed | 2.15e-04 | 26 | 29 | 2 | 24742657 | ||
| Pubmed | 2.33e-04 | 27 | 29 | 2 | 32878924 | ||
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 2.50e-04 | 28 | 29 | 2 | 29212953 | |
| Pubmed | 2.88e-04 | 30 | 29 | 2 | 32324134 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 3.26e-04 | 736 | 29 | 5 | 29676528 | |
| Pubmed | 3.49e-04 | 33 | 29 | 2 | 26071364 | ||
| Pubmed | The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airways. | 3.49e-04 | 33 | 29 | 2 | 23213461 | |
| Pubmed | Activation of beta-catenin signaling programs embryonic epidermis to hair follicle fate. | 3.49e-04 | 33 | 29 | 2 | 18480165 | |
| Pubmed | 3.62e-04 | 167 | 29 | 3 | 22159717 | ||
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 3.70e-04 | 34 | 29 | 2 | 30894540 | |
| Pubmed | Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development. | 3.70e-04 | 34 | 29 | 2 | 23123965 | |
| Cytoband | 1p34.1 | 6.02e-04 | 57 | 29 | 2 | 1p34.1 | |
| GeneFamily | Laminin subunits | 7.62e-05 | 12 | 20 | 2 | 626 | |
| GeneFamily | CD molecules|Mucins | 2.41e-04 | 21 | 20 | 2 | 648 | |
| Coexpression | NABA_MATRISOME | 6.34e-07 | 1008 | 28 | 9 | MM17056 | |
| Coexpression | NABA_MATRISOME | 7.35e-07 | 1026 | 28 | 9 | M5889 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.88e-05 | 191 | 28 | 4 | MM17059 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP | 5.39e-05 | 196 | 28 | 4 | M7588 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.39e-05 | 196 | 28 | 4 | M3008 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_DN | 9.14e-05 | 82 | 28 | 3 | M42504 | |
| Coexpression | KIM_GASTRIC_CANCER_CHEMOSENSITIVITY | 1.41e-04 | 95 | 28 | 3 | M14702 | |
| Coexpression | NABA_CORE_MATRISOME | 1.86e-04 | 270 | 28 | 4 | MM17057 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 1.90e-04 | 105 | 28 | 3 | M12602 | |
| Coexpression | NABA_CORE_MATRISOME | 1.99e-04 | 275 | 28 | 4 | M5884 | |
| Coexpression | FOROUTAN_TGFB_EMT_DN | 2.07e-04 | 108 | 28 | 3 | M42502 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.38e-08 | 143 | 29 | 5 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.38e-08 | 143 | 29 | 5 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-06 | 159 | 29 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 108 | 29 | 3 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.96e-05 | 110 | 29 | 3 | 518b21e5af2db1c8bfe7acf3cfff502897053ca8 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.72e-05 | 133 | 29 | 3 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 138 | 29 | 3 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | remission-multiplets|remission / disease stage, cell group and cell class | 1.22e-04 | 149 | 29 | 3 | e9974260a5f2999b363f306cae005698c912893a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 150 | 29 | 3 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 158 | 29 | 3 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 161 | 29 | 3 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 167 | 29 | 3 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 171 | 29 | 3 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-04 | 172 | 29 | 3 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.93e-04 | 174 | 29 | 3 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-04 | 175 | 29 | 3 | eaec7fda07a9537d067ca13b607a8ab201caa7c4 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 175 | 29 | 3 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 176 | 29 | 3 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.03e-04 | 177 | 29 | 3 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-04 | 178 | 29 | 3 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-04 | 178 | 29 | 3 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 182 | 29 | 3 | 8b16a13d8606d21a7a9ce1175237e9b4cf832ee0 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 186 | 29 | 3 | 744bf39af2fb5a7454477174d7755a6d78cd279f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-04 | 186 | 29 | 3 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 186 | 29 | 3 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-04 | 186 | 29 | 3 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | mild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.35e-04 | 186 | 29 | 3 | 5b2e1a58916f392fa1156bf9210df528775248ff | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 186 | 29 | 3 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.35e-04 | 186 | 29 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-04 | 190 | 29 | 3 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-04 | 191 | 29 | 3 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-04 | 191 | 29 | 3 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 191 | 29 | 3 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.58e-04 | 192 | 29 | 3 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.58e-04 | 192 | 29 | 3 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-04 | 195 | 29 | 3 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-04 | 195 | 29 | 3 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.74e-04 | 196 | 29 | 3 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.74e-04 | 196 | 29 | 3 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.74e-04 | 196 | 29 | 3 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-04 | 196 | 29 | 3 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.74e-04 | 196 | 29 | 3 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-04 | 197 | 29 | 3 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.78e-04 | 197 | 29 | 3 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-04 | 197 | 29 | 3 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.78e-04 | 197 | 29 | 3 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.78e-04 | 197 | 29 | 3 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-04 | 197 | 29 | 3 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 199 | 29 | 3 | 258d59cf811bf1668ffbb5f18f961021f660de62 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 200 | 29 | 3 | cd3c638961144a2fc91c437a173cc37c7452fa74 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.90e-04 | 200 | 29 | 3 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| Drug | Cerebro | 5.96e-06 | 28 | 29 | 3 | CID000005354 | |
| Disease | Sjogren's syndrome (is_marker_for) | 1.53e-06 | 24 | 28 | 3 | DOID:12894 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 6.73e-05 | 13 | 28 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 2.04e-04 | 121 | 28 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | age at menarche | 2.18e-04 | 594 | 28 | 5 | EFO_0004703 | |
| Disease | colon carcinoma | 2.78e-04 | 26 | 28 | 2 | EFO_1001950 | |
| Disease | ulcerative colitis (is_marker_for) | 6.62e-04 | 40 | 28 | 2 | DOID:8577 (is_marker_for) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 9.93e-04 | 49 | 28 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.44e-03 | 59 | 28 | 2 | EFO_0009658, GO_0009410 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.53e-03 | 61 | 28 | 2 | DOID:3587 (is_marker_for) | |
| Disease | pulse pressure measurement | 1.68e-03 | 1392 | 28 | 6 | EFO_0005763 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.82e-03 | 257 | 28 | 3 | DOID:10652 (is_marker_for) | |
| Disease | stomach cancer (is_implicated_in) | 2.13e-03 | 72 | 28 | 2 | DOID:10534 (is_implicated_in) | |
| Disease | lung cancer (is_implicated_in) | 2.25e-03 | 74 | 28 | 2 | DOID:1324 (is_implicated_in) | |
| Disease | Lung diseases | 2.49e-03 | 78 | 28 | 2 | C0024115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CFCPGGSEYYCYSKC | 541 | Q9Y2T1 | |
| ECRALCEGPYDYDGY | 241 | Q32P28 | |
| CQPEYTGDRCQYYVC | 4311 | Q9NZR2 | |
| RYYCYCGKVEDPPLD | 231 | Q6ZNB6 | |
| LEVPYAYQCCPYGMC | 471 | Q9HBX8 | |
| CYNLEGDYYCACPDD | 551 | Q9Y219 | |
| CRHYYYAGVCVPACP | 251 | P08069 | |
| CPVYCDYYNAPGECR | 1536 | Q7Z5P9 | |
| EPYCAICTLFYPYCQ | 681 | O94953 | |
| CPLFCDYYNPEGQCE | 1161 | P98088 | |
| RCDTCVPGAYNFPYC | 706 | O15230 | |
| MHPYCCCDLHPYPYC | 41 | Q14990 | |
| CCDLHPYPYCLCYSK | 46 | Q14990 | |
| YPYEHECNPYCPFRC | 146 | Q9H336 | |
| LGDCYYCICGLPDYR | 366 | O60266 | |
| YCRNPDAVAAPYCYT | 76 | P08519 | |
| NYCRNPDAVAAPYCY | 531 | P08519 | |
| YCRNPDAVAAPYCYT | 646 | P08519 | |
| YTCSCYPGFYGPECE | 181 | P16109 | |
| YPGFYGPECEYVREC | 186 | P16109 | |
| YCEPHDYEYCCPCEW | 286 | Q17RS7 | |
| RPYCCNYENCGKAYT | 281 | Q5JT82 | |
| CGYSSSCCGYRPLCY | 61 | Q3LI59 | |
| CPCYYYPNRAGSSDR | 4381 | Q9P225 | |
| CAYIFYPRPQNVEYC | 431 | P37088 | |
| AYDCYVAVCNPLRYP | 116 | Q8NH01 | |
| YAGPNCERCAPGYYG | 161 | Q16363 | |
| PAAHCPCYYCRQRYV | 521 | A2VEC9 | |
| CDYHYGFCDVIPPNC | 2111 | A5YKK6 | |
| YNCGYKPYRCDVCNY | 501 | Q9C0A1 | |
| CFYGKCYYCRETEPA | 196 | O75063 | |
| VCYRQYYPPLTDAEC | 226 | Q8NEB5 | |
| ERPYACDQCPYACAQ | 256 | Q8WUU4 |